drugset
drugset / Trial / NCT04071080

The Study of Oral Fluorescite to Confirm the Authenticity of Point of Care Urine Samples

NCT04071080 ↗

Phase 1 Completed 40 enrolled UpTru Inc. Medicor Research Inc. · collab
RandomizedParallel-groupDouble-blindScreening

Summary

During this study, participants will ingest 100 mg of fluorescein disodium or a placebo (no drug) mixed in GatoradeTM. Participants will then provide a urine sample after 10, 15, 20 or 30 minutes to see if the investigator can detect fluorescein fluorescence (light) in the urine.

Timeline

Start
2019-08-22
Primary completion
2019-11-28
Completion
2019-11-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluorescein Diagnostic / imaging agent 100 mg Oral

Indications

No indication recorded.